Investors Encouraged to Join Class Action Against LifeMD, Inc. After Losses

Class Action Suit for LifeMD Shareholders

LifeMD, Inc. (NASDAQ: LFMD) has recently come under scrutiny as shareholders are alerted to potential securities fraud that allegedly led to significant financial losses. The Gross Law Firm has issued an important notice urging those who purchased shares during the defined class period of May 7, 2025, to August 5, 2025, to take immediate action.

Background

During the outlined period, it is alleged that LifeMD's leadership made materially false statements regarding the company's business operations and growth prospects. Reports indicate that the company may have widely overstated its competitive position and improperly accounted for rising customer acquisition costs, particularly in its RexMD segment and drug sales targeting obesity treatment, including popular medications like Wegovy and Zepbound.

These misrepresentations could have led investors to believe higher returns were on the horizon, only for the opposite to unfold. The repercussions were disastrous for many investors who relied on the misleading information, resulting in a plunge in stock value as the facts became evident.

Call to Action

The Gross Law Firm is urging those affected to consider registration for participation in the ongoing class action. Interested shareholders should not delay, as the deadline to seek lead plaintiff status in the suit is set for October 25, 2025. Lead plaintiff status, while beneficial, is not a requisite for participating in potential recovery.

By registering, shareholders will gain exclusive access to a portfolio monitoring system that provides updates and insights throughout the life of the case.

Why Choose The Gross Law Firm?

The Gross Law Firm is renowned nationally for its commitment to safeguarding investor rights. Their mission centers on protecting those who have endured hardships as a result of deceptive business practices. The firm emphasizes the importance of maintaining ethical standards in corporate governance and aims to pursue a fair recovery for investors subjected to losses due to misleading corporate statements. They have a track record of success in similar cases, positioning them as an ally for investors embroiled in challenging financial circumstances.

For inquiries or to submit your registration, investors can reach out directly to The Gross Law Firm via their dedicated website or contact methods listed in their publicly shared notices.

In summary, if you were an investor in LifeMD, Inc. during the disclosed period and experienced losses, consider taking action now to receive the necessary support and guidance in navigating this class action process. Standing vigilant is essential to ensure fair treatment in the wake of corporate misrepresentation.

Contact Information:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: [email protected]
Phone: (646) 453-8903

Ensure that you mark October 25, 2025, on your calendar and connect with The Gross Law Firm to learn more about your rights and participation in this class action suit.